Target intelligence / Profile preview

PROK2 divergent transcript (PROK2-DT)

Target
PROK2-DT
Molecular classification
Long non-coding RNA, divergent transcript
01

Overview

PROK2 divergent transcript (PROK2-DT, also known as TCONS_00006091 or LOC105377156) is classified as a long non-coding RNA (lncRNA) that is transcribed divergently, meaning it originates in the opposite direction from a nearby protein-coding gene—specifically, from the region surrounding the PROK2 gene. Divergent transcripts defined by the HUGO Gene Nomenclature Committee (HGNC) are typically lncRNAs located within 300–500 nucleotides of a protein-coding gene[3][4]. There is no evidence that PROK2-DT encodes a protein or serves as a conventional molecular target for therapeutics such as receptors, enzymes, or ion channels. The function of PROK2-DT is currently unknown; for many divergent lncRNAs, roles are postulated in regulating the expression of neighboring protein-coding genes, but specific biological functions for this gene have not been established in the literature[1][3][4]. There are no associated drugs, mechanisms of action, recognized biomarkers, or known disease roles at this time.

Other names
TCONS_00006091LOC105377156PROK2-DT
02

Biological functions

Possibly gene regulation (as with other divergent lncRNAs)other (due to lack of established function)

Beyond the preview

Go deeper on PROK2 divergent transcript (PROK2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PROK2 divergent transcript (PROK2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call